Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-25FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal XR (lamotrigine) submitted by GlaxoSmithKline LLC. This action authorizes changes r…
-
FDA approval · 2025-04-25FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC.
-
FDA approval · 2025-04-21FDA Approved: LITHIUM CARBONATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Lithium Carbonate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals), indicating an appr…
-
FDA approval · 2025-04-15FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for lurasidone hydrochloride, enabling the generic to be marketed in the United…
-
FDA approval · 2025-04-15FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for divalproex sodium.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-02FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2025-03-27FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium (divalproex) by Aurobindo Pharma Limited. The approval pertains to the generic…
-
FDA approval · 2025-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for ZIPRASIDONE HYDROCHLORIDE, a generic form of ziprasidone, indicating appro…
-
EMA approval · 2025-02-26EMA Authorised: Aripiprazole Accord (aripiprazole) — Accord Healthcare S.L.U.
The EMA authorised Aripiprazole Accord as a generic aripiprazole product for schizophrenia and bipolar disorder.
-
FDA approval · 2025-02-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application from Bionpharma Inc. for aripiprazole (generic), enabling its continued commercialization with the a…
-
FDA approval · 2025-02-14FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for aripiprazole from Bionpharma Inc., enabling the generic product to be marketed in the United Sta…
-
FDA approval · 2025-01-29FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals' generic olanzapine and fluoxetine combination product.
-
FDA approval · 2025-01-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental application for aripiprazole (ARIPIPRAZOLE) under the ANDA pathway.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole from Alembic Pharmaceuticals, enabling the marketing of a generic version. This…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole, authorizing a generic ARIPIPRAZOLE product with the same in…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application from Apotex Corp. for aripiprazole (ANDA204094), authorizing changes to the generic product's approv…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for aripiprazole oral from Camber Pharmaceuticals, resulting in approval of this generic product's l…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole from VistaPharm, LLC, for a generic aripiprazole product.
-
FDA approval · 2025-01-23FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic aripiprazole, authorizing a generic formulation of the antipsychotic.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application to authorize a new orally disintegrating tablet formulation of aripiprazole from Dr. Reddy's Laborat…
-
FDA approval · 2025-01-23FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for risperidone from Amici Pharma, Inc., updating the drug's labeling and/or indications. This actio…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole (ARIPIPRAZOLE) under ANDA216351.